drugset / Trial / NCT01342367
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is see if quality of life is improved in patients receiving oral hormone therapy compared to standard of care. The study will also compare survival rates between patients receiving oral hormone therapy and those receiving standard of care.
Timeline
- Start
- 2010-12-17
- Primary completion
- 2020-05-01
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | 50 mg | Oral |
| Subject | Dutasteride | Small molecule | 0.5 mg | Oral |
| Subject | Finasteride | Small molecule | 5 mg | Oral |